wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26752277-12B3912E-1A83-4FD6-9D60-E237938C0EE2
Q26752277-12B3912E-1A83-4FD6-9D60-E237938C0EE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752277-12B3912E-1A83-4FD6-9D60-E237938C0EE2
Cancer immunotherapy: the beginning of the end of cancer?
P2860
Q26752277-12B3912E-1A83-4FD6-9D60-E237938C0EE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752277-12B3912E-1A83-4FD6-9D60-E237938C0EE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a9e684a4a88aade813419103fbfc4894653ffb2
P2860
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.